» Articles » PMID: 15117283

Domain Structure of Bi-functional Selenoprotein P

Overview
Journal Biochem J
Specialty Biochemistry
Date 2004 May 1
PMID 15117283
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Human selenoprotein P (SeP), a selenium-rich plasma glycoprotein, is presumed to contain ten selenocysteine residues; one of which is located at the 40th residue in the N-terminal region and the remaining nine localized in the C-terminal third part. We have shown that SeP not only catalyses the reduction of phosphatidylcholine hydroperoxide by glutathione [Saito, Hayashi, Tanaka, Watanabe, Suzuki, Saito and Takahashi (1999) J. Biol. Chem. 274, 2866-2871], but also supplies its selenium to proliferating cells [Saito and Takahashi (2002) Eur. J. Biochem. 269, 5746-5751]. Treatment of SeP with plasma kallikrein resulted in a sequential limited proteolysis (Arg-235-Gln-236 and Arg-242-Asp-243). The N-terminal (residues 1-235) and C-terminal (residues 243-361) fragments exhibited enzyme activity and selenium-supply activity respectively. These results confirm that SeP is a bi-functional protein and suggest that the first selenocysteine residue is the active site of the enzyme and the remaining nine residues function as a selenium supplier.

Citing Articles

Selenium and Selenoproteins: Mechanisms, Health Functions, and Emerging Applications.

Shahidin , Wang Y, Wu Y, Chen T, Wu X, Yuan W Molecules. 2025; 30(3).

PMID: 39942544 PMC: 11820089. DOI: 10.3390/molecules30030437.


Selenoproteins: Zoom-In to Their Metal-Binding Properties in Neurodegenerative Diseases.

Duta C, Muscurel C, Dogaru C, Stoian I Int J Mol Sci. 2025; 26(3).

PMID: 39941073 PMC: 11818150. DOI: 10.3390/ijms26031305.


Hepatokines and their role in cardiohepatic interactions in heart failure.

Shouman W, Najmeddine S, Sinno L, Dib Nehme R, Ghawi A, Ziade J Eur J Pharmacol. 2025; 992:177356.

PMID: 39922419 PMC: 11862882. DOI: 10.1016/j.ejphar.2025.177356.


"Alphabet" Selenoproteins: Their Characteristics and Physiological Roles.

Dogaru C, Muscurel C, Duta C, Stoian I Int J Mol Sci. 2023; 24(21).

PMID: 37958974 PMC: 10650576. DOI: 10.3390/ijms242115992.


"Alphabet" Selenoproteins: Implications in Pathology.

Dogaru C, Duta C, Muscurel C, Stoian I Int J Mol Sci. 2023; 24(20).

PMID: 37895024 PMC: 10607139. DOI: 10.3390/ijms242015344.


References
1.
Kryukov G, Castellano S, Novoselov S, Lobanov A, Zehtab O, Guigo R . Characterization of mammalian selenoproteomes. Science. 2003; 300(5624):1439-43. DOI: 10.1126/science.1083516. View

2.
Hirashima M, Naruse T, Maeda H, Nozaki C, Saito Y, Takahashi K . Identification of selenoprotein P fragments as a cell-death inhibitory factor. Biol Pharm Bull. 2003; 26(6):794-8. DOI: 10.1248/bpb.26.794. View

3.
Saito Y, Yoshida Y, Akazawa T, Takahashi K, Niki E . Cell death caused by selenium deficiency and protective effect of antioxidants. J Biol Chem. 2003; 278(41):39428-34. DOI: 10.1074/jbc.M305542200. View

4.
Tomokiyo K, Nakatomi Y, Araki T, Teshima K, Nakano H, Nakagaki T . A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa.... Vox Sang. 2003; 85(4):290-9. DOI: 10.1111/j.0042-9007.2003.00365.x. View

5.
Hill K, Zhou J, McMahan W, Motley A, Burk R . Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J Nutr. 2004; 134(1):157-61. DOI: 10.1093/jn/134.1.157. View